Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents

Nature Biotechnology volume 25, pages 1105–1106 (2007)Cite this article

A recent Supreme Court decision has introduced some uncertainty regarding the determination of obviousness of an invention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. KSR International Co. v. Teleflex Inc. (No. 04-1350).

  2. US Patent No. 6,237,565.

  3. US Patent No. 5,460,061.

  4. US Patent No. 5,819,593.

  5. US Patent No. 5,063,811.

  6. 298 F. Supp. 2d 581; 2003.

  7. Teleflex Ind. v KSR International Co. 04-1152 (119 Fed. Appx. 282; 2005).

  8. Syngenta Seeds, Inc. v. Monsanto Co., 2007 US App. LEXIS 10496 (Fed. Cir. May 3, 2007).

  9. Pfizer v. Apotex (06-1261).

  10. Papesch, 315 F.2d 381.

  11. Sanofi v. Apotex 02 Civ. 2255 (US Dist. 2007).

  12. US Patent No. 4,847, 265.

  13. Takeda Chem. Indus. et al. v. Alphapharm et al., No. 06-1329 (Fed. Cir. 2007).

Download references

Author information

Authors and Affiliations

  1. Rachel Teitelbaum and Mark Cohen are at Pearl Cohen Zedek Latzer LLP, 1500 Broadway, 12th Floor, New York, New York 10036, USA. rachelt@pczlaw.com,

    Rachel Teitelbaum & Mark Cohen

Authors
  1. Rachel Teitelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teitelbaum, R., Cohen, M. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Nat Biotechnol 25, 1105–1106 (2007). https://doi.org/10.1038/nbt1007-1105

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1007-1105

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing